Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Research

• Publication date

  2002-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12067990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic analysis of early- versus late-stage ovarian tumors.

  2001cited by this paper
• Coordinately up-regulated genes in ovarian cancer.

  2001cited by this paper
• Advances in the detection of chromosomal aberrations using spectral karyotyping

  2001cited by this paper
• IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival.

  2001cited by this paper
• Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

  2001cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis

  2000cited by this paper
• Ovarian cancer: epidemiology, biology, and prognostic factors.

  2000influential reference
• Comparative genomic hybridization: uses and limitations.

  2000cited by this paper
• Incidence of P53 and K‐ras alterations in ovarian mucinous and serous tumors

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Molecular classification of cutaneous malignant melanoma by gene expression profiling

  2000cited by this paper
• Development of a prostate cDNA microarray and statistical gene expression analysis package

  2000cited by this paper
• Cancer gene discovery using digital differential display.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.

  2000cited by this paper
• Genetic Aberrations Detected by Comparative Genomic Hybridization in Ovarian Clear Cell Adenocarcinomas

  2000cited by this paper
• Genomic-scale gene expression profiling of normal and malignant immune cells.

  2000cited by this paper
• Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance

  2000cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

  2000cited by this paper
• An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.

  2000cited by this paper
• Identification by cDNA microarray of genes involved in ovarian carcinogenesis.

  2000cited by this paper
• Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays

  2000cited by this paper
• Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables.

  2000cited by this paper
• Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.

  2000cited by this paper
• Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: A possible association with calcification of psammoma bodies

  2000cited by this paper
• Identification of a High Frequency of Chromosomal Rearrangements in the Centromeric Regions of Prostate Cancer Cell Lines by Sequential Giemsa Banding and Spectral Karyotyping

  2000cited by this paper
• PIK3CA is implicated as an oncogene in ovarian cancer

  1999cited by this paper
• DNA microarray technology: the anticipated impact on the study of human disease.

  1999cited by this paper
• In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin.

  1999cited by this paper
• Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.

  1999cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases

  1999cited by this paper
• Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray.

  1999cited by this paper
• Transforming growth factor-β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth

  1999cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: II. prognostic impact of nonrandom chromosome abnormalities in 244 cases

  1999cited by this paper
• Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis

  1999cited by this paper
• Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization

  1999cited by this paper
• Functional calcium-sensing receptor expression in ovarian surface epithelial cells.

  1998cited by this paper
• Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.

  1998cited by this paper
• Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization.

  1998cited by this paper
• Several genes encoding ribosomal proteins are over‐expressed in prostate‐cancer cell lines: Confirmation of L7a and L37 over‐expression in prostate‐cancer tissue samples

  1998cited by this paper
• Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.

  1998cited by this paper
• Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-gamma and TNF-alpha.

  1998cited by this paper
• Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-γ and TNF-α

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Band 1p36 abnormalities and t(1;17) in ovarian carcinoma.

  1997cited by this paper
• Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells

  1997cited by this paper
• Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas

  1997cited by this paper
• Mechanisms of escape from CD8+ T‐cell clones specific for the HER‐2/NEU proto‐oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression

  1997cited by this paper
• Treaty Draft Raises Scientific Hackles

  1996cited by this paper
• A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.

  1996cited by this paper
• Use of a cDNA microarray to analyse gene expression patterns in human cancer

  1996cited by this paper
• Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.

  1996influential reference
• Chromosome abnormalities in primary endometrioid ovarian carcinoma.

  1996cited by this paper
• Multicolor Spectral Karyotyping of Human Chromosomes

  1996cited by this paper
• Clonal chromosome abnormalities in 54 cases of ovarian carcinoma.

  1994cited by this paper
• Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma

  1994cited by this paper
• Current protocols in human genetics

  1994cited by this paper
• Modes of DAPI banding and simultaneous in situ hybridization

  1993cited by this paper
• Cytogenetic studies of epithelial ovarian carcinoma.

  1993influential reference
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• Chromosome aberrations in 35 primary ovarian carcinomas

  1992cited by this paper
• Prognostic impact of chromosome aberrations in ovarian cancer.

  1992cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Cytogenetic studies in ovarian cancer.

  1984cited by this paper
• An international system for human cytogenetic nomenclature

  1978cited by this paper

• Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells

  2021cites this paper
• Integration of Genomic Profiling and Organoid Development in Precision Oncology

  2021cites this paper
• Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles

  2020cites this paper
• Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis

  2019cites this paper
• Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis

  2019cites this paper
• The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples

  2017cites this paper
• Explorer Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma

  2017influential citation
• Molecular mechanisms underlying the action of histone deacetylases inhibitors (HDACIs) in ovarian cancer

  2017cites this paper
• Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer

  2016cites this paper
• Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

  2016cites this paper
• Fuzzy inheritance: A novel form of somatic cell inheritance that regulates cell population heterogeneity

  2016influential citation
• Inherent variability of cancer-specific aneuploidy generates metastases

  2016cites this paper
• Tumor heterogeneity has important consequences for personalized medicine in ovarian cancer.

  2015cites this paper
• Tumors of the Female Genital Organs

  2015cites this paper
• Ovarian cancer evolution through stochastic genome alterations: defining the genomic role in ovarian cancer

  2014influential citation
• Identification and Characterization of a Stem Cell-Like Population in Ovarian Cancer

  2014cites this paper
• Evolution of Pre-Existing versus Acquired Resistance to Platinum Drugs and PARP Inhibitors in BRCA-Associated Cancers

  2014cites this paper
• Advances in Biotechnology

  2014cites this paper
• The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma

  2013influential citation
• Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.

  2013cites this paper
• The role of tandem duplicator phenotype in tumour evolution in high‐grade serous ovarian cancer

  2012cites this paper
• Molecular and Cellular Pathobiology LRP 1 B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin

  2012cites this paper
• Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples

  2012cites this paper
• Identification of the a kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma

  2012cites this paper
• LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.

  2012cites this paper
• Genetic analysis of liver metastatic cell lines with different metastatic potential.

  2011cites this paper
• Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

  2011cites this paper
• Characterization of FOXO3a as a suppressor of lung adenocarcinoma

  2011cites this paper
• Molecular targets for liver cancer therapy: From screening of target genes to clinical trials

  2010cites this paper
• Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma

  2010influential citation
• Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats

  2010cites this paper
• High dimensional data analysis for new insight in ovarian cancer phenotypes

  2010cites this paper
• Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer

  2010cites this paper
• Somatic Genetic Development in Epithelial Ovarian Cancer

  2009cites this paper
• Genomic Markers for Ovarian Cancer at Chromosomes 1, 8 and 17 Revealed by Array CGH Analysis

  2009cites this paper
• Molecular Genetic Analysis of a Cell Adhesion Molecule With Homology to L1CAM, Contactin 6, and Contactin 4 Candidate Chromosome 3p26pter Tumor Suppressor Genes in Ovarian Cancer

  2009cites this paper
• Simple structural chromosomal abnormalities in advanced stage of ovarian cancer.

  2009cites this paper
• Large‐scale genomic analysis of ovarian carcinomas

  2009cites this paper
• Molecular pathogenesis of serous Fallopian tube and ovarian carcinoma

  2009cites this paper
• Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer

  2009influential citation
• Copy Number Changes in 1q21.3 and 1q23.3 have Different Clinical Relevance in Ovarian Tumors

  2009cites this paper
• Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization

  2008cites this paper
• The use of array‐based comparative genomic hybridization (a‐CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus

  2008cites this paper
• Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cells

  2008cites this paper
• Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

  2008cites this paper
• Screening of liver-targeted drugs

  2008cites this paper
• GENOMIC AND TRANSCRIPTOME PROFILING OF EPITHELIAL OVARIAN CANCER

  2008cites this paper
• Fluorescence In Situ Hybridization

  2008cites this paper
• Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.

  2008cites this paper
• Analiza zjawiska utraty heterozygotyczności (LOH) w chromosomach 3, 11, X w guzach nowotworowych kobiet ze sporadyczną i dziedziczną postacią raka jajnika

  2008cites this paper
• Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer

  2007cites this paper
• SKY analysis of childhood neural tumors and cell lines demonstrates a susceptibility of aberrant chromosomes to further rearrangements.

  2007cites this paper
• TITLE : Emerging Roles for PAX 8 in Ovarian Cancer and Endosalpingeal Development

  2007cites this paper
• Genomic mechanisms and measurement of structural and numerical instability in cancer cells.

  2007cites this paper
• Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours

  2007cites this paper
• Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.

  2007cites this paper
• Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.

  2007cites this paper
• Tight junction formation in epithelial ovarian adenocarcinoma

  2007cites this paper
• Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer?

  2007cites this paper
• Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

  2007cites this paper
• Molecular Markers in Epithelial Ovarian Cancer

  2007cites this paper
• Anomalie chromosomowe w diagnostyce nowotworów jajnika

  2007cites this paper
• DNA profiling of primary serous ovarian and Fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation‐dependent probe amplification

  2007cites this paper
• Prenatal Genomic Profiling of Abdominal Wall Defects through Comparative Genomic Hybridization: Perspectives for a New Diagnostic Tool

  2007cites this paper
• A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma

  2007cites this paper
• The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study

  2006cites this paper
• Transposable elements--is there a link between evolution and cancer?

  2006cites this paper
• Molecular predictors of response and outcome in ovarian cancer.

  2006cites this paper
• Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).

  2006cites this paper
• Genomic tests for ovarian cancer detection and management.

  2006cites this paper
• Operational criteria for selecting a cDNA microarray data normalization algorithm.

  2006cites this paper
• Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.

  2006cites this paper
• Computational Immunology : from MHC-peptide Binding to Immunotherapy

  2006cites this paper
• Mechanisms of transcoelomic metastasis in ovarian cancer.

  2006cites this paper
• Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas

  2006cites this paper
• Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality.

  2006cites this paper
• Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours.

  2006cites this paper
• Chromosomal losses of regions on 5q and lack of high‐level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma

  2006cites this paper
• Molecular prognostic markers in ovarian cancer: toward patient‐tailored therapy

  2006cites this paper
• Uncovering Biomarkers and Genetic Pathways in Ovarian Carcinoma

  2006cites this paper
• Quantification of random genomic mutations

  2005cites this paper
• A model-based scan statistic for identifying extreme chromosomal regions of gene expression in human tumors

  2005influential citation
• Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

  2005cites this paper
• Emerging issues of the expression profiling technologies for the study of gynecologic cancer.

  2005cites this paper
• The multiplicity of mutations in human cancers.

  2005cites this paper
• Gene Expression Profiles of Serous , Endometrioid , and Clear Cell Subtypes ofOvarianand Endometrial Cancer

  2005cites this paper
• High-Resolution Mapping of Genomic Imbalance and Identification of Gene Expression Profiles Associated with Differential Chemotherapy Response in Serous Epithelial Ovarian Cancer 1 *

  2005cites this paper
• Multivariate Projection Approaches for Microarray Analysis

  2005cites this paper
• High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.

  2005cites this paper
• Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.

  2005cites this paper
• In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer.

  2005cites this paper
• Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

  2005cites this paper
• Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

  2005cites this paper
• Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

  2005cites this paper
• Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy

  2005cites this paper
• Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.

  2004cites this paper
• Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.

  2004cites this paper
• The use of cytogenetics in understanding ovarian cancer.

  2004cites this paper
• Comparative Genomic Hybridization

  2004cites this paper
• Endometriosis and the neoplastic process.

  2004cites this paper